Catalyst Wire Dossier Catalyst Wire Dossier

Ciprofloxacin Extended-Release (Cipro XR)

ciprofloxacin · Bayer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ciprofloxacin Extended-Release (Cipro XR), covering 2009-06-26 to 2009-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens [Phase 4]

See pricing